Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1998
11/18/1998EP0688312B1 New derivatives of glutamic acid, a method of preparing them, and their use as drugs for enhancing memory and learning
11/18/1998EP0573498B1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents
11/18/1998CN1199400A 8-azabicycle [3.2.1]oct-2-ene derivs, their preparation and use
11/18/1998CN1199399A Naphthamide derivs, of 3-beta-amino azabicyclo octane or nonane as neuroleptic agents
11/18/1998CN1199398A 1-[2-(2,3-dihydro-1H-inden-1-yl) ethyl]-4-(naphthalen-1-yl) piperazine derivs, preparation thereof and therapeutical use thereof
11/18/1998CN1199397A Pyrimidin derivatives
11/18/1998CN1199338A Novel fused isoquinolines as dopamine receptor ligands
11/18/1998CN1199335A Pharmaceutical preparation contg. nimesulide for topical use
11/17/1998US5837815 Amino acid sequences with phosphorylation activity
11/17/1998US5837737 Hydrazinedicarboximidamide compounds and pharmaceutical composition comprising same
11/17/1998US5837730 Reducing the side-effect of glycine for treating nervous system disorder, psychological disorder
11/17/1998US5837724 Administering darifenacin or salt with acetylcholinesterase inhibitor; alzheimer's disease
11/17/1998US5837720 N-2-(pyrrolidinyl-1)-1-phenethyl) acetamides as kappa receptor antagonists
11/17/1998US5837717 Hydroxamic acid anesthetic compounds
11/17/1998US5837716 Analgesics
11/17/1998US5837712 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
11/17/1998US5837707 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/17/1998US5837705 An antagonist of excitatory amino acid and glycine receptor for treating neurodegenerative disorder, stroke, hypoglycemia, ischemic attack, anoxia or epilepsy
11/17/1998US5837702 4-arylamino-benzopyran and related compounds
11/17/1998US5837700 Therapeutic methods and delivery systems utilizing sex steroid precursors
11/17/1998US5837694 Method for enhancing neurone survival and agents useful for same
11/17/1998US5837532 Herpes simplex cirus type 1 mutant
11/17/1998US5837525 Polypeptides
11/17/1998US5837508 Hce3p83 polypeptides and polynucleotides used in the design of protocols for treatment of alzheimer's disease, stroke, cancer, inflammation, arthritis, musculoskeletal disease, heart disease, kidney disease and diagnostic assays for such
11/17/1998US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998US5837449 Hybridizable oligonucleotides; genetic engineering; diagnosis, detection and treatment of brain disorders such as alzheimer*s disease
11/17/1998US5837284 Oral dosage form of dl-threo methylphenidate hydrochloride; daily dosage; includes ammonio methacrylate polymer
11/17/1998US5837244 Treating a cell proliferative disorder
11/13/1998CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998WO1998050420A1 Serine protease inhibitors
11/12/1998WO1998050415A1 Pregnane 3,2o diol mono- and di-sulphates
11/12/1998WO1998050413A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens
11/12/1998WO1998050412A1 Estrogenic 19-noradnrost-17-one derivatives with an aromatic b-ring
11/12/1998WO1998050411A1 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alp ha-diol-20-one 3-sulfate useful as progestins and cns disorders
11/12/1998WO1998050410A1 Salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity
11/12/1998WO1998050385A1 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
11/12/1998WO1998050384A1 Tricyclic pyridone analogues as gaba-a receptor ligands
11/12/1998WO1998050383A1 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
11/12/1998WO1998050382A1 Amidine derivatives as inhibitors of nitric oxide synthase
11/12/1998WO1998050381A1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
11/12/1998WO1998050380A1 Compounds
11/12/1998WO1998050372A1 Substituted heterocycles and their use in medicaments
11/12/1998WO1998050364A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/12/1998WO1998050363A1 Substituted tetrahydro isoquinolines as modulators of dopamine d3 receptors
11/12/1998WO1998050358A1 Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity
11/12/1998WO1998050073A1 Integrin ligand, human mindin
11/12/1998WO1998050062A1 Compositions and methods of therapy for igf-i-responsive conditions
11/12/1998WO1998050052A1 Novel use of phospholipids of animal origin in therapy and/or dietetics
11/12/1998WO1998050044A1 Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
11/12/1998WO1998050042A1 Pregnan-3-ol-20-ones
11/12/1998WO1998050037A1 Anxiolytics
11/12/1998WO1998050027A1 Method of improving disturbed behavior and elevating mood in humans
11/12/1998WO1998035951A3 New aminopiperazine derivatives
11/12/1998CA2289190A1 Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
11/12/1998CA2289108A1 Salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity
11/12/1998CA2289096A1 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alpha-diol-20-one 3-sulfate useful as progestins and cns disorders
11/12/1998CA2289095A1 Pregnane 3,20 diol mono- and di-sulphates
11/12/1998CA2289008A1 Estrenes
11/12/1998CA2289006A1 Pregnan-3-ol-20-ones
11/12/1998CA2289001A1 Novel heterocyclic compounds
11/12/1998CA2288999A1 B-ring estratrienes
11/12/1998CA2288899A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/12/1998CA2288693A1 Method of improving disturbed behavior and elevating mood in humans
11/12/1998CA2288662A1 Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity
11/12/1998CA2288333A1 Amidine derivatives as inhibitors of nitric oxide synthase
11/12/1998CA2287999A1 Compounds
11/12/1998CA2287929A1 Tricyclic pyridone analogues as gaba-a receptor ligands
11/12/1998CA2287913A1 Substituted tetrahydro isoquinolines as modulators of dopamine d3 receptors
11/12/1998CA2287569A1 Serine protease inhibitors
11/11/1998EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998EP0876818A2 Agent for treating neuro-degenerative disorders
11/11/1998EP0876487A1 Mammalian cx 3?c chemokine genes
11/11/1998EP0876483A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor
11/11/1998EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998EP0876379A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
11/11/1998EP0876378A1 3,4-DIHYDRO 1,2,4]THIADIAZINO 3,4-b]BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
11/11/1998EP0876372A1 Heteroarylcarboxamide derivatives
11/11/1998EP0876371A1 Reverse-turn mimetics and methods relating thereto
11/11/1998EP0876368A1 Use of mono- or diketone tetracyclic derivatives, resulting novel compounds and therapeutical use thereof
11/11/1998EP0876367A1 Trans apovincaminic acid ester derivatives as drugs
11/11/1998EP0876357A1 New quinoxalindione derivatives, their preparation and use in medicaments
11/11/1998EP0876356A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
11/11/1998EP0876350A1 Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives
11/11/1998EP0876141A2 Preparations of non-steroidal analgesics
11/11/1998EP0720609B1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
11/11/1998EP0691970B1 Imidazoloquinoxalinone derivatives as eaa antagonists
11/11/1998EP0687266B1 Heterocyclic compounds and their preparation and use
11/11/1998EP0583271B1 Arylmorpholine, preparation and use
11/11/1998CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation
11/11/1998CN1198743A Pyrimidine derivatives as 5HT2c-receptor antagonists
11/11/1998CN1198741A Imidazole derivatives having affinity for alpha 2 receptors activity
11/11/1998CN1198739A (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-YL)-1-propanolmethanesulfonate trihydrate
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/11/1998CN1040645C Compound with 5-HT4 receptor rivalry activity, its preparation and pharmaceutical composition containing said compound
11/10/1998US5834593 Genetic engineering of prion protein
11/10/1998US5834508 Ketone derivatives
11/10/1998US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition
11/10/1998US5834495 Crystalline xamoneline tartrate
11/10/1998US5834494 Pyridylcarbamoyl Indolines
11/10/1998US5834493 Treatment of nervous system disorders
1 ... 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 ... 1833